Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Curr Eye Res ; 40(8): 830-8, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25266876

RESUMEN

PURPOSE: Staphylococcus aureus infection of the anterior chamber can occur after cataract surgery, causing inflammation and extensive damage to the iris. Alpha-toxin, the most potent S. aureus corneal toxin, was tested as a possible mediator of damage to the iris, and alpha-toxin anti-serum and a chemical toxin inhibitor were tested as potential pathology-reducing agents. METHODS: The hemolytic activity of alpha-toxin and its inhibition by a chemical inhibitor or anti-serum were quantified in vitro. Purified alpha-toxin, heat-inactivated toxin, or alpha-toxin plus normal serum, alpha-toxin anti-serum, or the chemical inhibitor, methyl-ß-cyclodextrin-cholesterol (CD-cholesterol), was injected into the rabbit anterior chamber. Pathological changes were photographed, quantified by slit-lamp examination (SLE) scoring, and further documented by histopathological analysis. RESULTS: At five hours post-injection, eyes injected with alpha-toxin or heat-inactivated toxin had a mean SLE score of 7.3 ± 0.59 or 0.84 ± 0.19, respectively. Active toxin caused moderate to severe iris edema, severe erosion of the iris, and mild to moderate fibrin accumulation in the anterior chamber. Alpha-toxin plus anti-serum or CD-cholesterol, in contrast to alpha-toxin alone, caused less iris edema and epithelium sloughing as well as significantly lower SLE scores than eyes receiving alpha-toxin alone (p ≤ 0.019). CONCLUSION: Alpha-toxin caused extensive iris damage and inflammation, and either anti-alpha-toxin anti-serum or CD-cholesterol was able to significantly reduce toxin-mediated damage and inflammation.


Asunto(s)
Toxinas Bacterianas/toxicidad , Edema/inducido químicamente , Exotoxinas/toxicidad , Proteínas Hemolisinas/toxicidad , Enfermedades del Iris/inducido químicamente , Iris/irrigación sanguínea , Neovascularización Patológica/inducido químicamente , Animales , Cámara Anterior/efectos de los fármacos , Anticuerpos Bloqueadores/uso terapéutico , Colesterol/uso terapéutico , Ensayo de Actividad Hemolítica de Complemento , Combinación de Medicamentos , Edema/patología , Edema/prevención & control , Inyecciones Intraoculares , Enfermedades del Iris/patología , Enfermedades del Iris/prevención & control , Neovascularización Patológica/patología , Neovascularización Patológica/prevención & control , Conejos , Lámpara de Hendidura , beta-Ciclodextrinas/uso terapéutico
2.
Ocul Immunol Inflamm ; 23(4): 297-303, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24912088

RESUMEN

PURPOSE: To investigate the effectiveness of a high-affinity human monoclonal antibody Fab fragment to Staphylococcus aureus alpha-toxin (LTM14 Fab) as therapy for S. aureus keratitis. METHODS: A single topical drop of the LTM14 Fab antibody to alpha-toxin alone, or in 0.006% benzalkonium chloride (BAK), was applied every 30 min to S. aureus-infected rabbit corneas from 9 to 14 hours post-infection. Erosions and pathology were measured at 15 h post-infection. RESULTS: LTM14 Fab with BAK limited corneal erosions better than LTM14 Fab alone (p = 0.036), and both limited erosions compared to untreated eyes (p ≤ 0.0001). Overall pathology was similar in all groups (p ≥ 0.070), but iritis and chemosis were reduced by treatment (p ≤ 0.036). CONCLUSIONS: The high-affinity human monoclonal Fab fragment antibody (LTM14 Fab) to S. aureus alpha-toxin was effective in reducing corneal damage during S. aureus keratitis.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...